-
EMA starts rolling review of Celltrion’s COVID-19 treatmentIndustryFeb 25, 2021European Medicines Agency said Wednesday, local time, that it has started a “rolling review” of data on South Korean company Celltrion’s monoclonal antibody regdanvimab. Regdanvimab, also known as C... -
Christopher Ko shares visions as Bio association representativeIndustryFeb 24, 2021South Korean biosimilar maker Samsung Bioepis’ CEO Christopher Ko on Wednesday carried out his first public event as the new chairperson of the Korea Bio Association. Korea Bio is an association rep... -
Elekta’s next-gen MRI device offers new hope for cancer patientsIndustryFeb 24, 2021Swedish medical device company Elekta wants to give renewed hopes to cancer patients through its next-generation radiotherapy device Unity. Elekta on Wednesday launched Unity in Korea, making it the... -
Korean experts advise Pfizer vaccine for 16 and olderIndustryFeb 23, 2021The first of the three-part evaluation of Pfizer’s COVID-19 vaccine here has shown the vaccine to be 95 percent effective and eligible for use on those aged 16 and older, South Korea’s Drug Ministry ... -
![[Herald Interview] Software dons role of therapeutics](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=649&simg=/content/image/2021/02/22/20210222000670_0.jpg)
[Herald Interview] Software dons role of therapeuticsIndustryFeb 22, 2021When talking about medical devices, conventional hardware with analytical or therapeutic functions for human health usually come to mind. But computer software that seeks to cure or alleviate sympto... -
Macrogen, Lifex Biolabs to research Parkinson’s treatmentIndustryFeb 22, 2021Precision life science company Macrogen will collaborate with US-based Lifex Biolabs on Parkinson’s disease treatment research, Macrogen announced Monday. This is a follow-up to Macrogen’s strategic... -
Samsung Display joins responsible business allianceIndustryFeb 21, 2021Samsung Display’s chief executive officer Choi Joo-sun is aiming to further embolden the company’s environmental, social and governance (ESG) involvement beginning this year. As part of this drive, ... -
Celltrion to take on S. Africa variantIndustryFeb 18, 2021Only a day after Celltrion began distribution of its monoclonal antibody therapy for COVID-19 in Korea, the company announced Thursday that it is setting out to tackle the more contagious South Afric... -
Celltrion begins distribution of COVID-19 therapy in KoreaIndustryFeb 17, 2021Celltrion began nationwide distribution of its monoclonal antibody therapy for COVID-19 on Wednesday. Celltrion’s regdanvimab is Korea’s first emergency-approved COVID-19 treatment. All 156 state-d... -
![[News Focus] More homegrown COVID-19 therapies coming](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=649&simg=/content/image/2021/02/16/20210216000844_0.jpg)
[News Focus] More homegrown COVID-19 therapies comingIndustryFeb 16, 2021Following Celltrion’s monoclonal antibody treatment for COVID-19, a slew of homegrown therapies is on the way in the first half of 2021. Chong Kun Dang Pharmaceutical is set to submit application fo... -
SK Bioscience to manufacture Novavax vaccine for 20 mil populationIndustryFeb 16, 2021South Korean vaccine-maker SK Bioscience will manufacture 40 million doses of US’ Novavax vaccines, enough to inoculate 20 million people. Under the agreement signed by SK Bioscience, Korea Disease ... -
Celltrion’s Humira biosimilar gains European sales approvalIndustryFeb 15, 2021Celltrion’s Yuflyma, an adalimumab biosimilar for autoimmune diseases, has been given the green light by the European Commission on Feb. 11, allowing for it to be sold in the European market, Celltri... -
![[Herald Interview] GenEdit to hone in on nervous system disorders in 2021 blueprint](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=649&simg=/content/image/2021/02/10/20210210000596_0.jpg)
[Herald Interview] GenEdit to hone in on nervous system disorders in 2021 blueprintIndustryFeb 13, 2021It was Christmas Eve in 2015. The seasonal festive vibe was blocked out from the science lab in UC Berkley, California, where bioengineering doctoral candidate Lee Gun-woo, then 27, was immersed in h... -
![[Newsmaker] South Korea approves AstraZeneca vaccine for all adults](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=649&simg=/content/image/2021/02/10/20210210000634_0.jpg)
[Newsmaker] South Korea approves AstraZeneca vaccine for all adultsIndustryFeb 10, 2021South Korea has approved the emergency use of AstraZeneca’s adenoviral vector COVID-19 vaccine for all adults, including those aged 65 and older, the Ministry of Food and Drug Safety said Wednesday. ... -
Korea open to Russian vaccine, GC Pharma rumored as CMOIndustryFeb 10, 2021GC Pharma has once again risen as a potential contract manufacturer to a foreign vaccine, this time for Russia’s Sputnik V. Company officials, however, refrained from commenting, citing the sensitiv...
MOST POPULAR
-
01[Feature] Why do old people pick up cardboard in Seoul?
-
New virus cases still rising 1 day before mass vaccine rollout02
-
03Hyundai to replace batteries in some 82,000 Kona, other EVs over fire risks
-
[Newsmaker] Koreas appear out of running for 2032 Olympics following IOC decision04
-
05[Newsmaker] Controversy brews over sex dolls in Korea
-
One day to go: AstraZeneca vaccines distributed across Korea06
-
07High hopes, stark reminders as Korea finally gets vaccines
-
Apple seeks greater presence in Korea with 2nd Apple Store08
-
09Tiger Woods suffers leg injuries after car rollover
-
Hyundai Motor to recall Kona electric cars over fire risk10